Andrew Guggenhime, President and CFO: Vaxcyte PCVX Sell · Filed 25/02/19

Trade details

Type: Insider sale
Amount: $517,062.48
Shares · price: 6,182 sh · $83.64 a share
Held after: 111,309 sh
Stock: Vaxcyte PCVX
Person: Andrew GuggenhimePresident and CFO
Trade date: 25/02/18
Filed: 25/02/19
Days to filing: 1 days

Sold 5.3% of holdings

Share of holding sold: 5.3%

Vaxcyte trades, last 26 weeks

What else happened in Vaxcyte around then

Filed or reported within 30 days of the trade day · 25/01/19~25/03/20

Andrew Guggenhime's recent trades

Andrew GuggenhimePresident and CFO
Planned sale10b5-1 planVaxcyte
Planned sale10b5-1 plan
Vaxcyte
PCVX
$539.9K
10,000 sh
$539.9K
Filed 08/03
Traded 08/03
Andrew GuggenhimePresident and CFO
Planned sale10b5-1 planVaxcyte
Planned sale10b5-1 plan
Vaxcyte
PCVX
$577.6K
10,000 sh
$577.6K
Filed 07/06
Traded 07/06
Andrew GuggenhimePresident and CFO
Sell10b5-1 planVaxcyte
Sell10b5-1 plan
Vaxcyte
PCVX
$530K
10,000 sh
$530K
Filed 06/18
Traded 06/18
Andrew GuggenhimePresident and CFO
Planned sale10b5-1 planVaxcyte
Planned sale10b5-1 plan
Vaxcyte
PCVX
$530K
10,000 sh
$530K
Filed 06/18
Traded 06/18
Andrew GuggenhimePresident and CFO
Sell10b5-1 planVaxcyte
Sell10b5-1 plan
Vaxcyte
PCVX
$153.8K
1,818 sh
$153.8K
Filed 25/02/19
Traded 25/02/18